ABOUT THE SERVICE
A novel inhaled therapy utilizing our proprietary nitric oxide technology for the treatment of chronic respiratory diseases, currently in Phase 1 clinical trials.
Information is owner-confirmed
Last updated 2 months ago
Price range
N/A